A double-blinded randomized trial on growth and feeding tolerance with Saccharomyces boulardii CNCM I-745 in formula-fed preterm infants
Objective: The use of probiotics is increasingly popular in preterm neonates, as they may prevent necrotizing enterocolitis sepsis and improve growth and feeding tolerance. There is only limited literature on Saccharomyces boulardii CNCM I-745 (S. boulardii) in preterm infants. Method: A prospective...
Main Authors: | Lingfen Xu, Yun Wang, Yang Wang, Jianhua Fu, Mei Sun, Zhiqin Mao, Yvan Vandenplas |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2016-05-01
|
Series: | Jornal de Pediatria |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0021755716000346 |
Similar Items
-
A double-blinded randomized trial on growth and feeding tolerance with Saccharomyces boulardii CNCM I-745 in formula-fed preterm infants
by: Lingfen Xu, et al.
Published: (2016-06-01) -
A double‐blinded randomized trial on growth and feeding tolerance with Saccharomyces boulardii CNCM I‐745 in formula‐fed preterm infants
by: Lingfen Xu, et al.
Published: (2016-05-01) -
Influence of Saccharomyces boulardii CNCM I-745 on the gut-associated immune system
by: Stier H, et al.
Published: (2016-09-01) -
Saccharomyces boulardii CNCM I-745 supplementation reduces gastrointestinal dysfunction in an animal model of IBS.
by: Paola Brun, et al.
Published: (2017-01-01) -
Protective effect of Saccharomyces boulardii CNCM I-745 on the development of inflammatory osteoclasts and inflammatory bone destruction
by: Maria-Bernadette Madel, et al.
Published: (2020-10-01)